Centessa Pharmaceuticals plc (CNTA)
NASDAQ·Healthcare·Biotechnology
$40.50
—
Mkt Cap $3.51B
Analyst Ratings
Buy
0
Hold
3
Sell
0
Price Target (17 analysts)
$39.50
Range $38.00 – $42.00
Implied Upside
-2.5%
Consensus $39.50 vs current $40.50
NASDAQ·Healthcare·Biotechnology
$40.50
—
Mkt Cap $3.51B
Buy
0
Hold
3
Sell
0
Price Target (17 analysts)
$39.50
Range $38.00 – $42.00
-2.5%
Consensus $39.50 vs current $40.50